The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday backed the Food and Drug Administration’s (FDA) decision to offer COVID-19 booster doses after five months, rather than six months. The recommendation applies to the Pfizer-BioNTech mRNA vaccine, according to the agency. The CDC still suggests that the Moderna and Johnson & Johnson recipients get their boosters six months and two months, respectively, after they get their initial vaccines. On Monday, the FDA said the new booster interval guidance applies to individuals aged 12 and older. “Following the FDA’s authorizations, today’s recommendations ensure people are able to get a boost of protection in the face of Omicron and increasing cases across the country, and ensure that the most vulnerable children can get an additional dose to optimize protection against COVID-19,” CDC Director Rochelle Walensky said in a news release. The CDC on Tuesday also suggested that moderately and severely immunocompromised 5-to …